Asim K. Debnath - Search Results

Year	Number of Results
1999	1
2002	5
2003	2
2004	5
2005	5
2006	3
2007	2
2008	5
2009	2
2010	2
2011	6
2012	5
2013	8
2014	3
2015	2
2016	3
2017	3
2018	2
2019	3
2020	3
2021	5
2022	1

1

Rational design of HIV-1 entry inhibitors.

Debnath AK. Debnath AK. Methods Mol Biol. 2013;993:185-204. doi: 10.1007/978-1-62703-342-8_13. Methods Mol Biol. 2013. PMID: 23568472 Review.

2

Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements.

Iusupov IR, Curreli F, Spiridonov EA, Markov PO, Ahmed S, Belov DS, Manasova EV, Altieri A, Kurkin AV, Debnath AK. Iusupov IR, et al. Among authors: debnath ak. Eur J Med Chem. 2021 Nov 15;224:113681. doi: 10.1016/j.ejmech.2021.113681. Epub 2021 Jul 7. Eur J Med Chem. 2021. PMID: 34246921

3

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Lu L, Yu F, Cai L, Debnath AK, Jiang S. Lu L, et al. Among authors: debnath ak. Curr Top Med Chem. 2016;16(10):1074-90. doi: 10.2174/1568026615666150901114527. Curr Top Med Chem. 2016. PMID: 26324044 Free PMC article. Review.

4

Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.

Curreli F, Ahmed S, Benedict Victor SM, Iusupov IR, Spiridonov EA, Belov DS, Altieri A, Kurkin AV, Debnath AK. Curreli F, et al. Among authors: debnath ak. Bioorg Med Chem. 2021 Feb 15;32:116000. doi: 10.1016/j.bmc.2021.116000. Epub 2021 Jan 8. Bioorg Med Chem. 2021. PMID: 33461144 Free PMC article.

5

α-Helix-Mimetic Foldamers for Targeting HIV-1 TAR RNA.

Maity D, Kumar S, Curreli F, Debnath AK, Hamilton AD. Maity D, et al. Among authors: debnath ak. Chemistry. 2019 May 28;25(30):7265-7269. doi: 10.1002/chem.201900139. Epub 2019 Apr 10. Chemistry. 2019. PMID: 30825250

6

HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites.

Losada N, Ruiz FX, Curreli F, Gruber K, Pilch A, Das K, Debnath AK, Arnold E. Losada N, et al. Among authors: debnath ak. J Med Chem. 2021 Nov 25;64(22):16530-16540. doi: 10.1021/acs.jmedchem.1c01104. Epub 2021 Nov 4. J Med Chem. 2021. PMID: 34735153

7

Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Yu F, Lu L, Du L, Zhu X, Debnath AK, Jiang S. Yu F, et al. Among authors: debnath ak. Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127. Viruses. 2013. PMID: 23344560 Free PMC article. Review.

8

Peptide and non-peptide HIV fusion inhibitors.

Jiang S, Zhao Q, Debnath AK. Jiang S, et al. Among authors: debnath ak. Curr Pharm Des. 2002;8(8):563-80. doi: 10.2174/1381612024607180. Curr Pharm Des. 2002. PMID: 11945159 Review.

9

Application of 3D-QSAR techniques in anti-HIV-1 drug design--an overview.

Debnath AK. Debnath AK. Curr Pharm Des. 2005;11(24):3091-110. doi: 10.2174/1381612054864902. Curr Pharm Des. 2005. PMID: 16178747 Review.

10

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.

Curreli F, Ahmed S, Victor SMB, Drelich A, Panda SS, Altieri A, Kurkin AV, Tseng CK, Hillyer CD, Debnath AK. Curreli F, et al. Among authors: debnath ak. Viruses. 2021 Dec 31;14(1):69. doi: 10.3390/v14010069. Viruses. 2021. PMID: 35062273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results